Oregon Neurology is excited to offer interested patients access to clinical trials, in addition to standard treatments. Participating in a clinical trial is a unique opportunity to help further medical research and potentially receive new medications before they are available to everyone. Our trials are typically in coordination with pharmaceutical companies and focus on providing access to new treatments or helping research existing therapies.
If you or someone you may know is interested in one of the following trials, please talk with your provider or call our office to speak with our clinical trials coordinator. Amazing things are happening here!
Myasthenia Gravis Trial
Trial: A Phase 2, Randomized, Double-Blind, placebo-controlled multi center study to evaluate the efficacy ad safety of ALXN2050 in adult Participants with generalized Myasthenia Gravis.
Principal Investigator: David Clark, DO
Sponsor: Alexion Pharmaceuticals, Inc.
Click here for more information about the Myasthenia Gravis Trial
Trial: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 4 Study to Evaluate the Efficacy and Safety of Qudexy® XR in the Prevention of Migraine in Children 6 to 11 Years of Age.
Principal Investigator: Jeffery Frank, MD
Sponsor: Upsher-Smith Laboratories, LLC
Click here for more information about the Pediatric Migraines Trial
*Not currently on the clinical trials directory.